ACHV Achieve Life Sciences Inc
Company Analysis
Latest News
🟢 ACHV is trading 5.4% up today extending rally on Russell index inclusion
ACHV is trading at $6.75 (+5.4%) in pre-market, extending a sharp multi-day rally following its recent addition to the Russell 2000 and Russell 3000...
🟢 ACHV is trading 6% up today after recent Russell 2000 index inclusion
ACHV is trading 5.8% up at $6.91 as it extends a multi-day rally following its recent addition to the Russell 2000 and Russell 3000 Indexes. • The inclusion...
Achieve Life Sciences joins Russell 2000, boosting visibility for nicotine treatment
Achieve Life Sciences will join the Russell 2000® and Russell 3000® Indexes. This inclusion takes effect after the U.S. market opens on June 29, 2026. The move...
Achieve Life Sciences earns Strong Buy, eyes 2027 launch after FDA setback
Raymond James reinstated coverage of Achieve Life Sciences on June 26, 2026, with a Strong Buy rating and a $20 price target. This endorsement follows a June...
🟢 ACHV is trading 5.8% up today after Raymond James resumed coverage with a Strong Buy rating and $20 price target
• Raymond James resumed coverage with a Strong Buy rating and $20 price target on June 26, 2026. • The stock is up 5.8% today at $6.03 and continues to build...
🟢 ACHV makes sharp 11.1% jump
ACHV is trading at $5.89, up 11.1% versus the comparison close of $5.30 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 ACHV is trading 6.6% up today as it extends rebound from FDA setback
ACHV is trading 6.6% up at $5.65 as it extends its recovery following a recent FDA setback for its smoking-cessation drug. • The stock rose 5.9% on June 24,...
🟢 ACHV is trading 5.9% up today as it rebounds from a recent FDA setback
ACHV is trading at $5.30 (up 5.9%), continuing a recovery following a sharp decline triggered by an FDA decision last week. • The FDA recently declined to...
🟢 Achieve Life Sciences Inc makes sharp 10.1% jump
ACHV is trading at $5.34, up 10.1% versus the comparison close of $4.85 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 Achieve Life Sciences Inc Rises 5.1% Following FDA Complete Response Letter for Cytisinicline NDA
• Achieve Life Sciences Inc. received a Complete Response Letter (CRL) from the FDA for its cytisinicline New Drug Application (NDA) today, June 22, 2026. •...
🔴 Achieve Life Sciences Inc drops 5% as FDA's cytisinicline decision date approaches with expected Complete Response Letter
Achieve Life Sciences Inc is trading at $5.09 (-5.04%) today. The decline comes as the Prescription Drug User Fee Act (PDUFA) date of June 20, 2026, for its...